Ann: Half Yearly Report and Accounts, page-5

Good news Viraleze sales up 30%.
I’d like to see online worldwide sales of VivaGel - Mundipharma left big gap in distribution. With online pharmaceuticals becoming more significant - attacking the Bacterial vaginosis treatment/prevention market dominated by repeat antibiotic scripts is important. Australia signatory of reduction in antibiotics in 2016.
The November 2024 review of the Poison Standard scheduling is an opportunity for dual scheduling of Astodrimer sodium for Bacterial vaginosis in sched2 for easy pharmacy sales and for those suffering recurrence or needing medical care as trying for pregnancy etc a chance for GPs to script under PBS sched4. We should hear soon on the interim delegates report from our submissions